Home Penumbra

Penumbra

In operation
IPO
Developer of Treatment Devices for Stroke and Other Neurovascular Diseases
Basic
Enterprise Profile
LinkedIn

Basic Information

Penumbra, Inc. develops clinically beneficial products to assist patients with stroke and other neurovascular diseases. It offers the Penumbra System, an ischemic stroke device platform; Penumbra Coil 400, for rapid aneurysm occlusion; 5MAX ACE, a clot extraction device used to engage and remove thrombus causing acute ischemia; and the Neuron System, a set of access catheters capable of delivering treatments to distal vessels in the brain.
Penumbra, Inc.
California,United States of America
more than 500 people
January 01, 2004
info@penumbrainc.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Manufacturing of Medical Equipment, Instruments, and Consumables
Technology
Smart Hardware
Concept
Neurosurgery Cardiology Department # Brain Sciences # Nervous System Diseases Adjuvant Therapy Products Peripheral Vascular Disease Cerebrovascular Disease (Stroke)
Application Scenarios
High-Value Medical Consumables Medical Devices